Cineverse clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Cineverse Corp
CNVS · NASDAQ · USD · Market cap $36M · 213 employees
Cineverse Corp.
Not yet scoredPrice as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 20:08 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.52 USD at the 6 Nov 2026 close
- Our regime readMarkdown, as of 7 Nov 2026
- Ethical screenNot yet scored
- Last reviewed6 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-06).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Cineverse Corp holds its Markdown at $1.52. Consolidating, no directional conviction, held for 77 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 77 days |
| Price at the screen | $1.52 |
| Valuation | N/A trailing · -11.62 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.71 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.18% | Below 33% | Interest-bearing debt is just 17.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 32.23% | Below 49% | Money owed to the company is 32.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Cineverse clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Cineverse clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +657% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | -11.6x |
| EPS, trailing | -0.56 |
| EPS, forward | -0.13 |
| Revenue growth | +175.2%growing very fast |
| Profit margin | -12.9%currently unprofitable |
| Return on equity | -28.4%not currently earning a positive return on equity |
| FCF yield | 28.27% |
| Debt to equity | 0.65moderate, manageable leverage |
| Current ratio | 0.75below 1: short-term bills exceed liquid assets |
| Beta | 1.71much more volatile than the market |
| Short interest, float | 0.02% |
| 52-week range | 1.50 - 3.44 |
| Moat | NONE |
| Market cap | $36M |
| Employees | 213 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCNVS trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 20.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 26.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 11.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (2 analysts) rates it none, with a mean price target of $11.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cineverse to Launch New 24/7 German Soccer Network, Available Exclusively on LG Channels Yahoo Finance · 26d ago
- Cineverse and DIRECTV Bring Home The Horror This October With SCREAMBOX Now Available as VOD Streaming Service Yahoo Finance · 8 Oct 2026
- Cineverse Brings Video Podcasts Bad Movies Rule!, Mohr Stories with Jay Mohr, and The Stand Presents: 10 for 10 to Amazon Fire TV Yahoo Finance · 29 Sep 2026
- Cineverse's RetroCrush Acquires Streaming Rights to Classic Anime Series and Films from VIZ Media Yahoo Finance · 27 Aug 2026
- Cineverse (CNVS) Q1 2027 Earnings Call Transcript Motley Fool · 20 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $2.56 | -0.4% | · | $996 | -0.4% |
| 2 months | $2.36 | +8.1% | · | $1,081 | +8.1% |
| 3 months | $2.70 | -5.6% | · | $944 | -5.6% |
| 6 months | $2.39 | +6.7% | · | $1,067 | +6.7% |
| 1 year | $3.70 | -31.1% | · | $689 | -31.1% |
| 2 years | $0.86 | +196.5% | · | $2,965 | +196.5% |
| 3 years | $4.04 | -36.9% | · | $631 | -36.9% |
| 5 years | $32.20 | -92.1% | · | $79 | -92.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CNVS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.